CollPlant Biotechnologies Ltd (CLGN) › Operating Cash FlowCollPlant Biotechnologies Ltd (CLGN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$1.22M2019: -$5.70M2020: -$4.45M2021: $2.50M2022: -$13.70M2023: -$2.76M2024: -$14.09M2025: -$9.42M-$9.42M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.42M+33.2%2024-$14.09M-410.1%2023-$2.76M+79.8%2022-$13.70M-647.7%2021$2.50M+156.2%2020-$4.45M+22.0%2019-$5.70M-368.6%2018-$1.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share